Published in AIDS Weekly, January 28th, 2002
"Heterologous prime/boost regimens are AIDS vaccine candidates because of their potential for inducing cellular immune responses," explained Tetsuro Matano and colleagues at the National Institute of Infectious Diseases' AIDS Research Center in Tokyo.
This strategy produced vigorous and persistent antiviral responses in animals, Matano and coauthors reported.
A cohort of rhesus macaques received a priming dose of env- and nef-deleted simian-human...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.